Parkinson's Disease (PD) is a progressive neurodegenerative disorder primarily affecting the motor system, with a global prevalence of 1% in individuals over 60. A comprehensive understanding of PD is crucial for healthcare professionals to facilitate optimal patient care.
PD is characterized by the degeneration of dopaminergic neurons in the substantia nigra, leading to dopamine deficiency. The etiology is multifactorial, involving genetic predisposition and environmental factors, with aging being the most significant risk factor.
Cardinal symptoms include bradykinesia, resting tremor, rigidity, and postural instability. Non-motor symptoms such as depression, cognitive impairment, and autonomic dysfunction are also common.
Treatment is symptomatic, with levodopa being the most effective medication. Deep Brain Stimulation (DBS) may be considered in advanced cases. Multidisciplinary care involving physiotherapy, occupational therapy, and neuropsychology is essential.
Comprehending the complexity of PD aids in its effective management. As healthcare professionals, we must stay abreast of the latest advancements in PD research to provide the best care for our patients.
1.
Q&A: Nipple-Sparing Mastectomy After Breast Radiation
2.
healthy despite having advanced cancer.
3.
Low-Dose Radiation Provides Almost Perfect Control Over Slow-Growing Lymphoma.
4.
PSMA-PET/CT Detects Metastatic Prostate Cancer Missed by Other Imaging
5.
The First Gene Therapy Provides a Durable Response for Non-Muscle-Invasive Bladder Cancer.
1.
Unlocking the Potential of Immune Checkpoint Inhibitors: A Pioneering Case Series on the Role of Immunotherapy in Microsatellite-Instability-High Colorectal Cancer
2.
An Overview Of Daunorubicin: What Is It Used For And How Does It Work?
3.
A New Hope: Exploring the Benefits of Exenteration for Cancer Patients
4.
Blood Donation Sustainability Through Behavioral Science
5.
Unlocking the Secrets of Follicular Cells: Exploring the Potential of Stem Cell Research
1.
Asian Symposium on Advancement in Hematology and Oncology
2.
Asian Symposium on Advancement in Hematology and Oncology
1.
Breaking Ground: ALK-Positive Lung Cancer Front-Line Management - Part V
2.
Pazopanib Takes Center Stage in Managing Renal Cell Carcinoma - Part V
3.
Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update)
4.
Lorlatinib in the Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update) - Conclusion
5.
An Eagles View - Evidence-based discussion on Iron Deficiency Anemia- Important Points to Know
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation